做多
$RXMD Rallying Off Buy Signal at Key Support in Telehealth Space
$RXMD has double-bottom key support lined up with a major MACD buy signal after breaking above its recent downtrend line in yesterday's action. This is a Coronavirus play at the leading edge in both telehealth and home pharmacy delivery.
• Telehealth regulations have been dropped to allow it to brace our healthcare system against exponential COVID-19 case growth.
• RXMD is currently priced at 0.5x trailing sales, which is extremely cheap, even for a pharmacy play.
• This is especially true given that it just posted 56% top-line growth and is moving toward the likely launch of a telemedicine platform.
• RXMD is moving toward a NASDAQ or NYSE uplisting.
• Telehealth regulations have been dropped to allow it to brace our healthcare system against exponential COVID-19 case growth.
• RXMD is currently priced at 0.5x trailing sales, which is extremely cheap, even for a pharmacy play.
• This is especially true given that it just posted 56% top-line growth and is moving toward the likely launch of a telemedicine platform.
• RXMD is moving toward a NASDAQ or NYSE uplisting.
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。